PharmacyCodes



Ciclizina [Inn-Spanish] en es it fr

Ciclizina [Inn-Spanish] Brand names, Ciclizina [Inn-Spanish] Analogs

Ciclizina [Inn-Spanish] Brand Names Mixture

  • No information avaliable

Ciclizina [Inn-Spanish] Chemical_Formula

C18H22N2

Ciclizina [Inn-Spanish] RX_link

No information avaliable

Ciclizina [Inn-Spanish] fda sheet

Ciclizina [Inn-Spanish] msds (material safety sheet)

Ciclizina [Inn-Spanish] Synthesis Reference

No information avaliable

Ciclizina [Inn-Spanish] Molecular Weight

266.381 g/mol

Ciclizina [Inn-Spanish] Melting Point

No information avaliable

Ciclizina [Inn-Spanish] H2O Solubility

No information avaliable

Ciclizina [Inn-Spanish] State

Solid

Ciclizina [Inn-Spanish] LogP

3.338

Ciclizina [Inn-Spanish] Dosage Forms

Liquid

Ciclizina [Inn-Spanish] Indication

For prevention and treatment of nausea, vomiting, and dizziness associated with motion sickness, and vertigo (dizziness caused by other medical problems).

Ciclizina [Inn-Spanish] Pharmacology

Cyclizine is a piperazine-derivative antihistamine used as an antivertigo/antiemetic agent. Cyclizine is used in the prevention and treatment of nausea, vomiting, and dizziness associated with motion sickness. Additionally, it has been used in the management of vertigo in diseases affecting the vestibular apparatus. Although the mechanism by which cyclizine exerts its antiemetic and antivertigo effects has not been fully elucidated, its central anticholinergic properties are partially responsible. The drug depresses labyrinth excitability and vestibular stimulation, and it may affect the medullary chemoreceptor trigger zone. It also possesses anticholinergic, antihistaminic, central nervous system depressant, and local anesthetic effects.

Ciclizina [Inn-Spanish] Absorption

No information avaliable

Ciclizina [Inn-Spanish] side effects and Toxicity

No information avaliable

Ciclizina [Inn-Spanish] Patient Information

No information avaliable

Ciclizina [Inn-Spanish] Organisms Affected

Humans and other mammals